local_hospital

ASOMHIDC - Individual practice "Cardio Tonus" EOOD

Address
zk Druzhba 2, bl, 284, entr A, fl 0, 1582 Sofia, Bulgaria

ASOMHIDC - Individual practice Cardio Tonus EOOD

ASOMHIDC - Individual practice Cardio Tonus EOOD is a specialized cardiovascular research facility focused on advancing the understanding and treatment of hypertensive disorders. The center demonstrates particular expertise in conducting Phase 3 clinical investigations of novel antihypertensive therapeutics, with emphasis on evaluating innovative pharmacological approaches for challenging blood pressure management scenarios.

  • Resistant and uncontrolled hypertension treatment strategies
  • Long-term safety and efficacy assessment of antihypertensive agents
  • Blood pressure control optimization in complex patient populations

The facility actively participates in comprehensive clinical trial programs including randomized treatment withdrawal studies and open-label extension protocols to evaluate both short-term efficacy and long-term safety profiles. Their research encompasses critical endpoints such as systolic blood pressure reduction, albuminuria improvement, and the assessment of novel aldosterone synthase inhibitors, contributing valuable data to the development of next-generation cardiovascular therapeutics for patients with difficult-to-control hypertension.

Site Overview

assignment
2
connected trials
corporate_fare
1
sponsor
science
2
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
1
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 476 other sites in Bulgaria

description
Trial volume
2
Outperforms 35% of sites
public
Therapeutic diversity
1areas
Outperforms 0% of sites
groups
Sponsor diversity
1sponsors
Outperforms 0% of sites

Therapeutic Area Benchmark — Bulgaria

Select a therapeutic area to compare against other sites in Bulgaria.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Bulgaria

Market Share

Country: Bulgaria

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in ASOMHIDC - Individual practice "Cardio Tonus" EOOD

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Long-Term Safety, Efficacy, and Tolerability Assessment of Lorundrostat in Hypertension: An Open-Label Extension StudyMineralys Therapeutics Inc.Phase IIINot RecruitingAug 2024

IMP list

lock Showing 1 of 2 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Lorundrostat2Unknown2024-04-172024-08-26

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.